Chavoc no problem asking questions as long as they intended in the right way and I think your concerns are very valid. I expressed the same matters myself and have never liked these funding options. They can be very dilutive but the company can overcome this with continued success at trials and creating a picture or showing the path to the commercial release of their intended products. Investor demand can easily cater for the dilution as long as we get that steady stream of news and there are no major delays. Personally I think they took a hit early to get on the front foot and have funding tied for a certain period of time. As you said this quarter seems to be sufficient covered. The question I have is where is the R & D rebate I can't find either of them in the last 2 quarterlies, am I going blind.
IVX Price at posting:
5.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)